Quantum Biopharma (QNTM) Short-term Investments (2019 - 2026)

Quantum Biopharma has disclosed Short-term Investments across 8 years of filings, most recently posting $222906.0 for Q1 2026.

• Short-term Investments for Q1 2026 came in at $222906.0, up 968.17% year-over-year; the trailing twelve-month figure through Mar 2026 was $222906.0 (up 968.17% YoY), and the FY2025 annual result was $459080.0, down 61.82% from the prior year.
• Short-term Investments came in at $222906.0 for Q1 2026 at Quantum Biopharma, down from $459080.0 in the prior quarter.
• In the past five years, Short-term Investments ranged from a high of $3.5 million in Q3 2024 to a low of -$22140.0 in Q1 2024.
• The 5-year median for Short-term Investments is $459080.0 (2025), against an average of $640546.1.
• Across the five-year window, Short-term Investments surged 11902.6% in 2023 and tumbled 103.4% in 2024, its largest moves.
• Quantum Biopharma's Short-term Investments stood at $6162.0 in 2022, then soared by 11902.6% to $739600.0 in 2023, then jumped by 62.57% to $1.2 million in 2024, then tumbled by 61.82% to $459080.0 in 2025, then tumbled by 51.45% to $222906.0 in 2026.
• The last three Short-term Investments figures came in at $222906.0 (Q1 2026), $459080.0 (Q4 2025), and $636761.0 (Q3 2025), per Business Quant data.